Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$510.68 - $643.45 $249,722 - $314,647
-489 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$454.43 - $535.6 $6.82 Million - $8.03 Million
-15,000 Reduced 96.84%
489 $252,000
Q2 2020

Aug 14, 2020

BUY
$334.87 - $493.06 $4.02 Million - $5.92 Million
12,000 Added 343.94%
15,489 $6.99 Million
Q1 2020

May 15, 2020

SELL
$320.01 - $409.07 $20.8 Million - $26.6 Million
-65,000 Reduced 94.91%
3,489 $1.22 Million
Q4 2019

Feb 14, 2020

BUY
$319.73 - $374.2 $1.12 Million - $1.31 Million
3,489 Added 5.37%
68,489 $25.3 Million
Q3 2019

Nov 14, 2019

BUY
$304.55 - $345.24 $19.8 Million - $22.4 Million
65,000 New
65,000 $21.6 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.32B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Perceptive Advisors LLC Portfolio

Follow Perceptive Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.